Clinicopathological Significance of MicroRNA-20b Expression in Hepatocellular Carcinoma and Regulation of HIF-1α and VEGF Effect on Cell Biological Behaviour

被引:26
作者
Xue, Tong-min [1 ]
Tao, Li-de [2 ]
Zhang, Miao [1 ]
Zhang, Jie [1 ]
Liu, Xia [1 ]
Chen, Guo-feng [1 ]
Zhu, Yi-jia [1 ]
Zhang, Pei-Jian [1 ]
机构
[1] Yangzhou Univ, Inst Gen Surg Res, Affiliated Hosp 2, Yangzhou 225002, Jiangsu, Peoples R China
[2] Nanjing Univ Chinese Med, Nanjing 210023, Jiangsu, Peoples R China
关键词
TUMOR PROGRESSION; DOWN-REGULATION; POOR-PROGNOSIS; FACTOR PATHWAY; MIR-20B; HYPOXIA; PATHOGENESIS; METASTASIS; MECHANISM; APOPTOSIS;
D O I
10.1155/2015/325176
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
miRNA-20b has been shown to be aberrantly expressed in several tumor types. However, the clinical significance of miRNA-20b in the prognosis of patients with hepatocellular carcinoma (HCC) is poorly understood, and the exact role of miRNA-20b in HCC remains unclear. The aim of the present study was to investigate the association of the expression of miR-20b with clinicopathological characteristics and overall survival of HCC patients analyzed by Kaplan-Meier analysis and Cox proportional hazards regression models. Meanwhile, the HIF-1 alpha and VEGF targets of miR-20b have been confirmed. We found not only miR-20b regulation of HIF-1 alpha and VEGF in normal but also regulation of miR-20b in hypoxia. This mechanism would help the tumor cells adapt to the different environments thus promoting the tumor invasion and development. The whole study suggests that miR-20b, HIF-1 alpha, and VEGF serve as a potential therapeutic agent for hepatocellular carcinoma.
引用
收藏
页数:10
相关论文
共 39 条
  • [1] The functions of animal microRNAs
    Ambros, V
    [J]. NATURE, 2004, 431 (7006) : 350 - 355
  • [2] MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004)
    Bartel, David P.
    [J]. CELL, 2007, 131 (04) : 11 - 29
  • [3] The Role of MicroRNAs in Human Liver Cancers
    Braconi, Chiara
    Henry, Jon C.
    Kogure, Takayuki
    Schmittgen, Thomas
    Patel, Tushar
    [J]. SEMINARS IN ONCOLOGY, 2011, 38 (06) : 752 - 763
  • [4] Identification of metastasis-related microRNAs in hepatocellular carcinoma
    Budhu, Anuradha
    Jia, Hu-Liang
    Forgues, Marshonna
    Liu, Chang-Gong
    Goldsteir, David
    Lam, Amy
    Zanetti, Krista A.
    Ye, Qing-Hai
    Qin, Lun-Yju
    Croce, Carlo M.
    Tang, Zhao-You
    Wang, Xin Wei
    [J]. HEPATOLOGY, 2008, 47 (03) : 897 - 907
  • [5] Burroughs SK, 2013, FUTURE MED CHEM, V5, P553, DOI [10.4155/FMC.13.17, 10.4155/fmc.13.17]
  • [6] miR-20b Modulates VEGF Expression by Targeting HIF-1α and STAT3 in MCF-7 Breast Cancer Cells
    Cascio, Sandra
    D'Andrea, Aleco
    Ferla, Rita
    Surmacz, Eva
    Gulotta, Eliana
    Amodeo, Valeria
    Bazan, Viviana
    Gebbi, Nicola
    Russo, Antonio
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2010, 224 (01) : 242 - 249
  • [7] Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in colorectal cancer
    Chen, Peng
    Xi, Qiulei
    Wang, Qiang
    Wei, Pei
    [J]. MEDICAL ONCOLOGY, 2014, 31 (10) : 1 - 6
  • [8] Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in hepatocellular carcinoma
    Chen, Ping
    Zhao, Xia
    Ma, Liang
    [J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 2013, 383 (1-2) : 49 - 58
  • [9] Dysregulated microRNAs in the pathogenesis and progression of cervical neoplasm
    Cheung, Tak-hong
    Man, Kwun-nok Mimi
    Yu, Mei-yung
    Yim, So-fan
    Siu, Nelson S. S.
    Lo, Keith W. K.
    Doran, Graeme
    Wong, Raymond R. Y.
    Wang, Vivian W.
    Smith, David I.
    Worley, Michael J., Jr.
    Berkowitz, Ross S.
    Chung, Tony K. H.
    Wong, Yick-fu
    [J]. CELL CYCLE, 2012, 11 (15) : 2876 - 2884
  • [10] Oncomirs - microRNAs with a role in cancer
    Esquela-Kerscher, A
    Slack, FJ
    [J]. NATURE REVIEWS CANCER, 2006, 6 (04) : 259 - 269